Scinai Immunotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement; Continues to Work with the European Investment Bank to Convert Loan to Equity to Regain Compliance with Nasdaq Minimum Shareholders' Equity Requirement
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameScinai Immunotherapeutics Ltd
-
Registration countryIsrael
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









